Welcome to our dedicated page for Aixin Life Intl SEC filings (Ticker: AIXN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Aixin Life Intl's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Aixin Life Intl's regulatory disclosures and financial reporting.
Aixin Life International (AIXN) reported another weak quarter for the three months ended September 30, 2025. Net revenue fell to $301,979 from $936,406 a year earlier, as direct sales and pharmacy revenue declined sharply, while hotel and manufacturing segments also generated lower sales. The company posted a quarterly net loss of $340,461, though this was narrower than the prior-year loss of $546,186.
For the first nine months of 2025, revenue dropped to $1.16 million from $3.12 million, and the net loss widened slightly to $1.41 million. Operating cash outflow increased to $1.77 million, partly funded by $3.28 million of advances from related parties, leaving cash at only $19,113 and a working capital deficit of $6.77 million. Total liabilities of $9.20 million, including $5.46 million due to related parties, exceed total assets of $3.37 million, resulting in a stockholders’ deficit of $5.82 million. Management discloses that these conditions raise substantial doubt about the company’s ability to continue as a going concern and plans to rely on cost controls, higher-margin products, related-party loans, and potential equity offerings.
AiXin Life International, Inc. filed a notice of late Form 10-Q for the quarter ended September 30, 2025, citing delays in completing its financial statements and related review procedures that it says could not be resolved without unreasonable effort or expense. The company expects to use the five-day extension period allowed under SEC rules.
Based on preliminary results, AiXin anticipates revenue of about $301,979 for the third quarter and $1,161,739 for the first nine months of 2025, down from $936,406 and $3,120,615 in the same 2024 periods. It expects a comprehensive loss of roughly $374,458 for the third quarter of 2025 versus a loss of $642,319 a year earlier, and a nine-month comprehensive loss of about $1,541,996 compared with $1,369,754 in 2024. The company states there is substantial doubt about its ability to continue as a going concern, and these preliminary figures do not reflect any potential adjustments that could result if it is unable to continue operating.
FAQ
What is the current stock price of Aixin Life Intl (AIXN)?
What is the market cap of Aixin Life Intl (AIXN)?
